---
figid: PMC151139__JCI0216568.f1
figtitle: Events proposed to cause nephrotoxic ARF
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC151139
filename: JCI0216568.f1.jpg
figlink: /pmc/articles/PMC151139/figure/F1/
number: F1
caption: Events proposed to cause nephrotoxic ARF. As indicated in the text, TNF-α
  participates in both an early, vascular phase and a later, proinflammatory phase
  in this response. Red arrows indicate points in the pathway where various protective
  therapies appear to interfere with nephrotoxicity.
papertitle: Cancer therapy and renal injury.
reftext: Robert W. Schrier. J Clin Invest. 2002 Sep 15;110(6):743-745.
year: '2002'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9430977
figid_alias: PMC151139__F1
figtype: Figure
redirect_from: /figures/PMC151139__F1
ndex: ac78b53d-deb5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC151139__JCI0216568.f1.html
  '@type': Dataset
  description: Events proposed to cause nephrotoxic ARF. As indicated in the text,
    TNF-α participates in both an early, vascular phase and a later, proinflammatory
    phase in this response. Red arrows indicate points in the pathway where various
    protective therapies appear to interfere with nephrotoxicity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - so
  - Sod2
  - Sod1
  - gp
  - Dif
  - dl
  - Rel
  - egr
  - lds
  - Rbf
  - Rb97D
  - Decay
  - amos
  - gfr
  - nac
  - Arl1
  - Arf1
  - Arl2
  - SOD1
  - SOD2
  - SOD3
  - NFKB1
  - IL10
  - TNF
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - RAPGEF5
  - CDKN2A
  - Cisplatin
  - cisplatin
---
